ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 23 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,769,000 | -30.0% | 5,975,000 | -34.4% | 0.09% | -41.3% |
| Q1 2017 | $9,666,000 | -45.7% | 9,109,000 | -41.0% | 0.15% | -34.8% |
| Q4 2016 | $17,789,000 | +72.8% | 15,439,000 | +85.1% | 0.23% | +49.4% |
| Q3 2016 | $10,292,000 | -37.8% | 8,340,000 | -45.2% | 0.15% | -38.6% |
| Q2 2016 | $16,535,000 | +21.1% | 15,211,000 | 0.0% | 0.25% | -35.3% |
| Q1 2016 | $13,651,000 | -7.9% | 15,211,000 | 0.0% | 0.39% | +21.6% |
| Q4 2015 | $14,829,000 | +3.7% | 15,211,000 | 0.0% | 0.32% | -5.3% |
| Q3 2015 | $14,296,000 | -18.0% | 15,211,000 | 0.0% | 0.34% | -14.7% |
| Q2 2015 | $17,425,000 | -0.1% | 15,211,000 | 0.0% | 0.40% | +13.5% |
| Q1 2015 | $17,445,000 | +88.2% | 15,211,000 | +72.1% | 0.35% | +93.3% |
| Q4 2014 | $9,269,000 | – | 8,840,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 46,542 | $43,298,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $7,370,000 | 0.75% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $1,388,000 | 0.60% |
| Perceptive Advisors | 15,000,000 | $13,846,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $14,296,000 | 0.34% |
| LINDEN ADVISORS LP | 3,500,000 | $3,258,000 | 0.22% |
| Visium Asset Management, LP | 6,500,000 | $6,067,000 | 0.08% |
| ZAZOVE ASSOCIATES LLC | 1,750,000 | $1,625,000 | 0.08% |
| Investors Capital Advisory Services | 326,000 | $300,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 15,969,000 | $14,771,000 | 0.04% |